BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11071270)

  • 21. Differential gene expression in ovarian carcinoma: identification of potential biomarkers.
    Hibbs K; Skubitz KM; Pambuccian SE; Casey RC; Burleson KM; Oegema TR; Thiele JJ; Grindle SM; Bliss RL; Skubitz AP
    Am J Pathol; 2004 Aug; 165(2):397-414. PubMed ID: 15277215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray.
    Han H; Bearss DJ; Browne LW; Calaluce R; Nagle RB; Von Hoff DD
    Cancer Res; 2002 May; 62(10):2890-6. PubMed ID: 12019169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors.
    Stull RA; Tavassoli R; Kennedy S; Osborn S; Harte R; Lu Y; Napier C; Abo A; Chin DJ
    BMC Genomics; 2005 Apr; 6():55. PubMed ID: 15836779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential gene expression between normal and tumor-derived ovarian epithelial cells.
    Ismail RS; Baldwin RL; Fang J; Browning D; Karlan BY; Gasson JC; Chang DD
    Cancer Res; 2000 Dec; 60(23):6744-9. PubMed ID: 11118061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemiluminescence based Ziplex automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip expression profiles.
    Quinn MC; Wilson DJ; Young F; Dempsey AA; Arcand SL; Birch AH; Wojnarowicz PM; Provencher D; Mes-Masson AM; Englert D; Tonin PN
    J Transl Med; 2009 Jul; 7():55. PubMed ID: 19580657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers.
    Jazaeri AA; Awtrey CS; Chandramouli GV; Chuang YE; Khan J; Sotiriou C; Aprelikova O; Yee CJ; Zorn KK; Birrer MJ; Barrett JC; Boyd J
    Clin Cancer Res; 2005 Sep; 11(17):6300-10. PubMed ID: 16144934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
    Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
    Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arrays of arrays for high-throughput gene expression profiling.
    Zarrinkar PP; Mainquist JK; Zamora M; Stern D; Welsh JB; Sapinoso LM; Hampton GM; Lockhart DJ
    Genome Res; 2001 Jul; 11(7):1256-61. PubMed ID: 11435408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array.
    Shim C; Zhang W; Rhee CH; Lee JH
    Clin Cancer Res; 1998 Dec; 4(12):3045-50. PubMed ID: 9865919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses.
    Tsuda H; Ito YM; Ohashi Y; Wong KK; Hashiguchi Y; Welch WR; Berkowitz RS; Birrer MJ; Mok SC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6880-8. PubMed ID: 16203778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels.
    Schmid MC; Bisoffi M; Wetterwald A; Gautschi E; Thalmann GN; Mitola S; Bussolino F; Cecchini MG
    Int J Cancer; 2003 Feb; 103(5):577-86. PubMed ID: 12494464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential gene expression in breast cancer cell lines and stroma-tumor differences in microdissected breast cancer biopsies revealed by display array analysis.
    Mellick AS; Day CJ; Weinstein SR; Griffiths LR; Morrison NA
    Int J Cancer; 2002 Jul; 100(2):172-80. PubMed ID: 12115566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of IL-17 mRNA in ovarian cancer.
    Kato T; Furumoto H; Ogura T; Onishi Y; Irahara M; Yamano S; Kamada M; Aono T
    Biochem Biophys Res Commun; 2001 Apr; 282(3):735-8. PubMed ID: 11401524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laser capture microdissection-generated target sample for high-density oligonucleotide array hybridization.
    Ohyama H; Zhang X; Kohno Y; Alevizos I; Posner M; Wong DT; Todd R
    Biotechniques; 2000 Sep; 29(3):530-6. PubMed ID: 10997267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-MYB activation and the pathogenesis of ovarian cancer.
    Barletta C; Lazzaro D; Prosperi Porta R; Testa U; Grignani F; Ragusa RM; Leone R; Patella A; Carenza L; Peschle C
    Eur J Gynaecol Oncol; 1992; 13(1):53-9. PubMed ID: 1547794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer.
    Lou Y; Jiang H; Cui Z; Wang X; Wang L; Han Y
    Int J Mol Med; 2018 Jul; 42(1):91-104. PubMed ID: 29577163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
    Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
    Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.
    Huddleston HG; Wong KK; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2005 Jan; 96(1):77-83. PubMed ID: 15589584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.